Organthis
Organthis offers organoid-based drug testing to tailor therapies for individual patients. It uses patient-specific organoids combined with AI-powered analytics through its OrganMatch platform to predict drug responses. This is a B2B biotech platform serving pharma and biotech developers. Key technologies include organoid culture, AI analytics, and a proprietary OrganMatch platform. The company aims to scale this approach to reduce R&D risk and accelerate clinical decision-making.
Organthis
Organthis offers organoid-based drug testing to tailor therapies for individual patients. It uses patient-specific organoids combined with AI-powered analytics through its OrganMatch platform to predict drug responses. This is a B2B biotech platform serving pharma and biotech developers. Key technologies include organoid culture, AI analytics, and a proprietary OrganMatch platform. The company aims to scale this approach to reduce R&D risk and accelerate clinical decision-making.